Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
21.25
-0.59 (-2.70%)
Feb 5, 2026, 4:00 PM EST - Market closed
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $6 billion as of February 6, 2026.
Market Cap
6.00B
Enterprise Value
5.67B
1-Year Change
n/a
Ranking
Category
Stock Price
$21.25
Market Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has increased from $5.95B to $6.00B, an increase of 0.69%. That is a compound annual growth rate of 1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 6.00B | -21.24% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytokinetics | 7.37B |
| Rhythm Pharmaceuticals | 6.93B |
| Belite Bio | 6.69B |
| Kymera Therapeutics | 6.08B |
| Mirum Pharmaceuticals | 5.88B |
| PTC Therapeutics | 5.81B |
| ImmunityBio | 5.56B |
| Cogent Biosciences | 5.43B |